Replimune Group, Inc. (REPL)
14.69
-0.08
(-0.54%)
USD |
NASDAQ |
Aug 24, 16:00
14.69
0.00 (0.00%)
After-Hours: 20:00
Replimune Group 1 Year Total Returns (Daily) : 163.8% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 163.8% |
| August 20, 2026 | 167.6% |
| August 19, 2026 | 180.5% |
| August 18, 2026 | 192.3% |
| August 17, 2026 | 163.1% |
| August 14, 2026 | 179.8% |
| August 13, 2026 | 198.4% |
| August 12, 2026 | 190.3% |
| August 11, 2026 | 173.5% |
| August 10, 2026 | 158.4% |
| August 07, 2026 | 120.1% |
| August 06, 2026 | 133.8% |
| August 05, 2026 | 87.18% |
| August 04, 2026 | 108.8% |
| August 03, 2026 | 56.71% |
| July 31, 2026 | 59.32% |
| July 30, 2026 | -28.34% |
| July 29, 2026 | 44.27% |
| July 28, 2026 | 68.77% |
| July 27, 2026 | 174.0% |
| July 24, 2026 | 212.9% |
| July 23, 2026 | 213.6% |
| July 22, 2026 | 283.2% |
| July 21, 2026 | -10.75% |
| July 20, 2026 | -13.07% |
| Date | Value |
|---|---|
| July 17, 2026 | -18.16% |
| July 16, 2026 | -24.62% |
| July 15, 2026 | -21.94% |
| July 14, 2026 | -12.50% |
| July 13, 2026 | -9.43% |
| July 10, 2026 | 2.04% |
| July 09, 2026 | 6.93% |
| July 08, 2026 | 19.06% |
| July 07, 2026 | 19.27% |
| July 06, 2026 | 22.02% |
| July 02, 2026 | 21.26% |
| July 01, 2026 | 22.62% |
| June 30, 2026 | 19.16% |
| June 29, 2026 | 20.04% |
| June 26, 2026 | 22.94% |
| June 25, 2026 | 17.78% |
| June 24, 2026 | 15.59% |
| June 23, 2026 | 23.73% |
| June 22, 2026 | 20.60% |
| June 18, 2026 | 7.38% |
| June 17, 2026 | 5.21% |
| June 16, 2026 | -10.68% |
| June 15, 2026 | -8.38% |
| June 12, 2026 | -10.17% |
| June 11, 2026 | -11.86% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Moderna, Inc. | 453.5% |
| Kalaris Therapeutics, Inc. | 68.70% |
| Arrowhead Pharmaceuticals, Inc. | 319.8% |
| Oncolytics Biotech, Inc. | -16.52% |
| Sangamo Therapeutics, Inc. | -75.17% |